Loading…
Learn how to assess assay compatibility, platform dependencies, consumables, regulatory limits, and sourcing risks before committing to a diagnostic workflow.
Learn why laboratories are moving beyond individual assay selection and evaluating platform compatibility, automation, workflow efficiency, and sourcing strategies when purchasing molecular diagnosti…
Antibody-drug conjugates (ADCs) continue to attract significant attention across oncology research. On July 6, 2026, Novartis announced an agreement to acquire Myricx Bio, a biotechnology company dev…
Multiomics research allows you to examine genomic, transcriptomic, proteomic, and other biological information within a connected study. However, combining these methods also makes laboratory procure…
Alzheimer’s blood testing is moving beyond the question of whether amyloid pathology is present. A 2026 NIH-supported study identified a 34-circRNA blood model that performed comparably to pTau217 fo…
